Computed tomography (CT) is less sensitive than magnetic resonance imaging (MRI) for the diagnosis of early prostate cancer, and MRI is now recognized as the best imaging method for diagnosing prostate cancer.
MRI can show the integrity of the prostate envelope and whether the tumor has invaded the surrounding prostate tissue and organs, as well as pelvic lymph node invasion and bone metastases. The multiparameter magnetic resonance imaging (Mp-MRI)-based prostate imaging report and data system (PI-RADS) scoring system is important in the diagnosis of prostate cancer. The PI-RADS classification system is of great importance in the diagnosis of prostate cancer.
However, the final diagnosis requires a pathological diagnosis obtained by prostate puncture biopsy.